5,12-bis(2-phenylethynyl)tetracene: Your Key Pharmaceutical Intermediate
The pharmaceutical industry relies on a vast array of chemical intermediates to synthesize life-saving drugs. Among these crucial compounds is 5,12-bis(2-phenylethynyl)tetracene (CAS: 18826-29-4), a complex organic molecule valued for its structural properties and potential applications in drug development. As a specialized pharmaceutical intermediate, understanding its characteristics and sourcing effectively is vital for R&D scientists and procurement professionals.
Understanding the Compound's Significance
5,12-bis(2-phenylethynyl)tetracene, with the CAS number 18826-29-4, is a derivative of naphthalene. Its molecular formula is C34H20, and it boasts a molecular weight of approximately 428.52 g/mol. Typically supplied as a white to off-white powder, it is stable under standard laboratory conditions. Its primary value lies in its role as a building block in organic synthesis, particularly for creating more complex molecules relevant to medicinal chemistry and materials science.
Why is it a Key Pharmaceutical Intermediate?
The specific arrangement of the phenylethynyl groups on the tetracene backbone gives this molecule unique electronic and structural properties. These characteristics can be leveraged in several ways within pharmaceutical research:
- Drug Discovery: As a scaffold or precursor, it can be modified to create novel drug candidates with specific biological activities.
- Synthesis of APIs: It serves as a critical intermediate in the multi-step synthesis of certain Active Pharmaceutical Ingredients (APIs).
- Materials for Drug Delivery: While less common, its conjugated system might be explored in advanced drug delivery systems or diagnostic agents.
The demand for high-purity intermediates like this compound means that pharmaceutical companies often seek out reliable manufacturers who can guarantee consistent quality and supply. When you decide to buy, sourcing from a reputable supplier in China, known for its robust chemical manufacturing capabilities, can offer significant advantages in terms of both product quality and competitive pricing.
Procurement Considerations for Pharmaceutical Intermediates
For professionals in the pharmaceutical sector, the procurement process for intermediates like 5,12-bis(2-phenylethynyl)tetracene (CAS: 18826-29-4) involves several critical steps:
- Quality Assurance: Confirming the purity (e.g., 95%min or higher) and checking for trace impurities through a Certificate of Analysis (CoA) is non-negotiable.
- Supplier Reliability: Partnering with established manufacturers or suppliers who understand the stringent requirements of the pharmaceutical industry is crucial for consistent batch-to-batch quality.
- Cost-Effectiveness: While quality is paramount, managing costs is also essential. Inquiring about price and potential bulk discounts from a manufacturer can optimize your budget.
- Regulatory Compliance: Ensure that the intermediate meets any relevant industry standards or regulatory requirements for its intended use.
We are a dedicated manufacturer and supplier specializing in high-quality chemical intermediates for the pharmaceutical and research sectors. Our commitment to purity, rigorous quality control, and efficient supply chain management ensures that you receive dependable 5,12-bis(2-phenylethynyl)tetracene (CAS: 18826-29-4) for your critical drug development projects. Reach out to us to discuss your requirements, obtain a quote, and secure a reliable supply of this vital pharmaceutical intermediate.
Perspectives & Insights
Agile Reader One
“These characteristics can be leveraged in several ways within pharmaceutical research:Drug Discovery: As a scaffold or precursor, it can be modified to create novel drug candidates with specific biological activities.”
Logic Vision Labs
“Synthesis of APIs: It serves as a critical intermediate in the multi-step synthesis of certain Active Pharmaceutical Ingredients (APIs).”
Molecule Origin 88
“Materials for Drug Delivery: While less common, its conjugated system might be explored in advanced drug delivery systems or diagnostic agents.”